Skip to main content
Clinical Trials/ChiCTR2000034058
ChiCTR2000034058Not yet recruitingEarly Phase 1

基于大数据分析和深度学习模型构建结直肠癌防治智能系统

浙江省科技厅1 site in 1 countryStarted: January 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Early Phase 1
Status
Not yet recruiting
Sponsor
Locations
1
Primary Endpoint
肠道菌群

Study Overview

Brief Summary

以肠道微生态组学研究为基础,构建新的治疗评价体系,为结直肠癌患者提供精准治疗方案的选择

Study Design

Study Type
诊断试验
Primary Purpose
析因分组(即根据危险因素或暴露因素分组)
Masking
未说明

Eligibility Criteria

Ages
20 to 75 (—)
Sex
All

Inclusion Criteria

  • 1.经肠镜活检病理确诊为结直肠癌的患者;
  • 2.本人或其代理人签署知情同意。

Exclusion Criteria

  • ⑴合并有其他恶性肿瘤;
  • ⑵合并有严重心肺疾病;
  • ⑶患者入院前 3 个月有抗生素、激素或肠道菌群制剂使用史;
  • ⑷严重腹泻或便秘的患者。

Outcomes

Primary Outcomes

肠道菌群

SEN, SPE, ACC, AUC of ROC

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
浙江省科技厅

Study Sites (1)

Loading locations...

Similar Trials

韩书文医师:该试验尚未获伦理委员会批准,请于批准后才开始征募参试者,并与我们联系上传伦... | Clinical Trial